MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $339,164 | +32.5% | 1,400 | -50.1% | 0.01% | -68.8% |
Q4 2019 | $256,000 | -35.5% | 2,807 | -39.0% | 0.02% | -33.3% |
Q3 2019 | $397,000 | -80.3% | 4,600 | -76.0% | 0.02% | -89.1% |
Q2 2019 | $2,012,000 | +163.4% | 19,200 | +214.8% | 0.22% | +76.8% |
Q1 2019 | $764,000 | – | 6,100 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PACIFIC VIEW ASSET MANAGEMENT, LLC | 25,070 | $2,825,000 | 3.32% |
HealthCor Management, L.P. | 688,890 | $77,652,000 | 2.43% |
Avoro Capital Advisors LLC | 225,000 | $25,362,000 | 1.52% |
EMORY UNIVERSITY | 17,038 | $1,921,000 | 1.51% |
Rock Springs Capital Management LP | 241,000 | $27,166,000 | 1.28% |
Baker Brothers Advisors | 1,169,278 | $131,801,000 | 1.08% |
Caption Management, LLC | 100,800 | $11,362,000 | 0.91% |
SHIKIAR ASSET MANAGEMENT INC | 14,341 | $1,617,000 | 0.84% |
Pier Capital, LLC | 37,654 | $4,244,000 | 0.84% |
Atika Capital Management LLC | 20,000 | $2,254,000 | 0.66% |